Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05415449 · ClinicalTrials.gov registry record

Exploration of Central Venous Catheter Protective Devices in the Pediatric Population: A Mixed Methods Study

A clinical trial of Central Line, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
30
Enrollment target
1
Study location

NCT05415449 is a study of Central Line that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05415449, a study of Central Line, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

1. to determine the feasibility of utilizing a wearable device 2. to prospectively measure and evaluate parent and nurse satisfaction with the protective wearable device. This is a sequential, convergent mixed methods study design in which qualitative interview data will be collected first followed by quantitative data. Scheme and Outcomes: Identify eligible patients--Informed Consent--Provide education and two protective wearable device--Demographic data (electronic health record)--Interview parent on device--Every month complete 30-day satisfaction survey for a total of three data collection period-Discharge from study. Nurse data collection scheme: Study participants hospitalized at time of enrollment in study or anytime during the study period. Nurse of patients using device will complete satisfaction survey. Note: Vest is a Class I Exempt FDA-registered device.

Conditions Studied

Interventions

  • DEVICE Gus gear protective wearable device

Study Locations (1)

Texas

  • Children's Health - Dallas

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-12-14
Est. Completion 2025-05-28

What the Registry Record Tells You About NCT05415449

The ClinicalTrials.gov registry entry for NCT05415449 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Central Line appearing as the primary indexed condition, and to 1 intervention - of which Gus gear protective wearable device is the first listed.

NCT05415449 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05415449 about?

NCT05415449 is a clinical study titled "Exploration of Central Venous Catheter Protective Devices in the Pediatric Population: A Mixed Methods Study". 1. to determine the feasibility of utilizing a wearable device 2. to prospectively measure and evaluate parent and nurse satisfaction with the protective wearable device. This is a sequential, convergent mixed methods study design in which qualitative interview data will be collected first followed...

What is the current status of trial NCT05415449?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2022-12-14. Estimated completion is 2025-05-28.

What conditions does trial NCT05415449 study?

This clinical trial studies the following conditions: Central Line.

What interventions are being tested in trial NCT05415449?

The interventions under investigation include: Gus gear protective wearable device (DEVICE).

Who is sponsoring clinical trial NCT05415449?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05415449 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.